ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS
- 7 November 1964
- journal article
- Published by Elsevier in The Lancet
- Vol. 284 (7367) , 990-991
- https://doi.org/10.1016/s0140-6736(64)90933-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- LIVER IN REGULATION OF FIBRINOLYTIC ACTIVITYThe Lancet, 1964
- Abnormal Plasminogen-Plasmin System Activity (Fibrinolysis) in Patients with Hepatic Cirrhosis: Its Cause and Consequences*Journal of Clinical Investigation, 1964
- Fractionation and characterization of an inhibitor of plasmin found in normal plasmaArchives of Biochemistry and Biophysics, 1964
- Inhibition of a Human Fibrinolytic System by Normal and Pathologic SeraExperimental Biology and Medicine, 1962
- Coagulation defects in patients with cirrhosis of the liver undergoing portasystemic shuntsThe American Journal of Surgery, 1962
- Studies on Spontaneous Fibrinolytic Activity In Patients with Cirrhosis of the Liver and Its Inhibition by Epsilon Amino Caproic AcidAnnals of Surgery, 1961
- Severe Thrombotic Disease in a Young Man with Bone Marrow and Skeletal Changes and with a High Content of an Inhibitor in the Fibrinolytic SystemActa Medica Scandinavica, 1961
- Fibrinolysis and Fibrinolytic Activity in ManPhysiological Reviews, 1959
- FIBRINOLYSIS FOLLOWING OPERATIONThe Lancet, 1937